4.7 Article

Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia

Journal

JOURNAL OF HEMATOLOGY & ONCOLOGY
Volume 8, Issue -, Pages -

Publisher

BIOMED CENTRAL LTD
DOI: 10.1186/s13045-015-0223-4

Keywords

Long non-coding RNA; Acute promyelocytic leukemia; All-trans retinoic acid; Differentiation

Funding

  1. National Natural Science Foundation of China [81400102]
  2. China Postdoctoral Science Foundation [2015 M570751]
  3. National undergraduate training program for innovation and entrepreneurship [201510559043]
  4. Medical Scientific Research Foundation of Guangdong Province, China [A2015420]

Ask authors/readers for more resources

Background: Acute promyelocytic leukemia (APL) is associated with chromosomal translocation t(15; 17), which results in the proliferation of morphologically abnormal promyelocytes. Gain of supernumerary copies of the 8q24 chromosomal region, which harbors MYC and PVT1, has been shown to be the most common secondary alteration in human APL. Increased MYC can accelerate the development of myeloid leukemia in APL. However, the role that the expression of the long non-coding RNA (lncRNA) PVT1 plays in the pathogenesis of APL remains largely unknown. Findings: In this study, we first analyzed the lncRNA PVT1 expression level in peripheral blood cells from 28 patients with de novo APL, and significantly upregulated PVT1 was found in APL patients compared with healthy donors. We then observed significantly lower MYC and PVT1 expression during all-trans retinoic acid (ATRA)-induced differentiation and cell cycle arrest in the APL cell line. MYC knockdown in NB4 cells led to PVT1 downregulation. Moreover, PVT1 knockdown by RNA interference led to suppression of the MYC protein level, and cell proliferation was inhibited. Conclusion: Our findings reveal that the lncRNA PVT1 may play an important role in the proliferation of APL cells and may be useful for future therapeutic management.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available